0.05-0.2 mg/day; or clonidine, 0.1-0.3 mg twice daily) or an open-label step 3 agent (hydralazine, 25-100 mg twice daily) could be added. In addition, a number of ALLHAT participants (n=10,337 ...

During the eight-week treatment phase, patients received either moxonidine (0.2 or 0.4 mg/day) or the ACE inhibitor ... acting antihypertensives such as clonidine is widely acknowledged but ...

The SGLT2 inhibitor empagliflozin (Jardiance) reduced the risk of creatinine increases and acute kidney injury (AKI) even in ...